Education
About Us
Working with TipRanks
Follow Us
ProMIS Neurosciences (PMN)
NASDAQ:PMN
Total Valuation
ProMIS Neurosciences has a market cap or net worth of $18.34M. The enterprise value is $17.66M.
Market Cap$18.34M
Enterprise Value$17.66M
Share Statistics
ProMIS Neurosciences has 32,689,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,689,190
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ProMIS Neurosciences’s return on equity (ROE) is -3.52 and return on invested capital (ROIC) is -330.86%.
Return on Equity (ROE)-3.52
Return on Assets (ROA)-0.97
Return on Invested Capital (ROIC)-330.86%
Return on Capital Employed (ROCE)-3.34
Revenue Per Employee0.00
Profits Per Employee-2.50M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ProMIS Neurosciences is -0.81. ProMIS Neurosciences’s PEG ratio is 0.05.
PE Ratio-0.81
PS Ratio―
PB Ratio2.84
Price to Fair Value2.84
Price to FCF-0.98
Price to Operating Cash Flow-0.98
PEG Ratio0.05
Income Statement
In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned -17.51M in profits. Earnings per share was -1.42.
Revenue0.00
Gross Profit-10.44M
Operating Income-18.90M
Pretax Income-17.51M
Net Income-17.51M
EBITDA-17.81M
Earnings Per Share (EPS)-1.42
Cash Flow
In the last 12 months, operating cash flow was -22.01M and capital expenditures 0.00, giving a free cash flow of -22.01M billion.
Operating Cash Flow-22.01M
Free Cash Flow-22.01M
Free Cash Flow per Share-0.67
Dividends & Yields
ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-71.72%
50-Day Moving Average0.71
200-Day Moving Average1.06
Relative Strength Index (RSI)40.15
Average Volume (3m)31.12K
Important Dates
ProMIS Neurosciences upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
ProMIS Neurosciences as a current ratio of 1.46, with Debt / Equity ratio of 0.00%
Current Ratio1.46
Quick Ratio1.46
Debt to Market Cap0.00
Net Debt to EBITDA0.94
Interest Coverage Ratio93.84
Taxes
In the past 12 months, ProMIS Neurosciences has paid -167.90K in taxes.
Income Tax-167.90K
Effective Tax Rate<0.01
Enterprise Valuation
ProMIS Neurosciences EV to EBITDA ratio is 0.14, with an EV/FCF ratio of 0.18.
EV to Sales0.00
EV to EBITDA0.14
EV to Free Cash Flow0.18
EV to Operating Cash Flow0.18
Balance Sheet
ProMIS Neurosciences has $21.57M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$21.57M billion.
Cash & Marketable Securities$21.57M
Total Debt$0.00
Net Cash-$21.57M
Net Cash Per Share-$0.66
Tangible Book Value Per Share$0.40
Margins
Gross margin is -187.14%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-187.14%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for ProMIS Neurosciences is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside971.43% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast98.61%